BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17118343)

  • 21. Regulation of breast cancer-associated aromatase promoters.
    Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
    Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.
    Wang Y; Man Gho W; Chan FL; Chen S; Leung LK
    Br J Nutr; 2008 Feb; 99(2):303-10. PubMed ID: 17761019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions.
    Takahashi-Shiga N; Utsunomiya H; Miki Y; Nagase S; Kobayashi R; Matsumoto M; Niikura H; Ito K; Yaegashi N
    Clin Cancer Res; 2009 Oct; 15(19):6028-34. PubMed ID: 19789322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of a dimer of 2-(4-pyridylmethyl)-1-indanone as a novel nonsteroidal aromatase inhibitor.
    Gupta R; Jindal DP; Jit B; Narang G; Palusczak A; Hartmann RW
    Arch Pharm (Weinheim); 2004 Jul; 337(7):398-401. PubMed ID: 15237390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of serotonergic 5-HT2A receptor signaling increases placental aromatase (CYP19) activity and expression in BeWo and JEG-3 human choriocarcinoma cells.
    Klempan T; Hudon-Thibeault AA; Oufkir T; Vaillancourt C; Sanderson JT
    Placenta; 2011 Sep; 32(9):651-656. PubMed ID: 21703684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
    Belosay A; Brodie AM; Njar VC
    Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?
    Morale MC; L'Episcopo F; Tirolo C; Giaquinta G; Caniglia S; Testa N; Arcieri P; Serra PA; Lupo G; Alberghina M; Harada N; Honda S; Panzica GC; Marchetti B
    Brain Res Rev; 2008 Mar; 57(2):431-43. PubMed ID: 18063054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian P450 aromatase activity in the catfish Heteropneustes fossilis: seasonal changes and effects of catecholestrogens.
    Chourasia TK; Joy KP
    Gen Comp Endocrinol; 2008 May; 156(3):537-43. PubMed ID: 18395205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA methylation of placenta-specific Cyp19 promoters of cattle and sheep.
    Vanselow J; Selimyan R; Fürbass R
    Exp Clin Endocrinol Diabetes; 2008 Jul; 116(7):437-42. PubMed ID: 18523913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxicity and aromatase (CYP19) activity modulation by organochlorines in human placental JEG-3 and JAR choriocarcinoma cells.
    Letcher RJ; van Holsteijn I; Drenth HJ; Norstrom RJ; Bergman A; Safe S; Pieters R; van den Berg M
    Toxicol Appl Pharmacol; 1999 Oct; 160(1):10-20. PubMed ID: 10502498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interference of endocrine disrupting chemicals with aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish.
    Cheshenko K; Pakdel F; Segner H; Kah O; Eggen RI
    Gen Comp Endocrinol; 2008 Jan; 155(1):31-62. PubMed ID: 17459383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of levetiracetam and valproate on reproductive endocrine function studied in human ovarian follicular cells.
    Taubøll E; Gregoraszczuk EL; Wojtowicz AK; Milewicz T
    Epilepsia; 2009 Aug; 50(8):1868-74. PubMed ID: 19490055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone metabolism in men: role of aromatase activity.
    Nuti R; Martini G; Merlotti D; De Paola V; Valleggi F; Gennari L
    J Endocrinol Invest; 2007; 30(6 Suppl):18-23. PubMed ID: 17721069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphenol A downregulates CYP19 transcription in JEG-3 cells.
    Huang H; Leung LK
    Toxicol Lett; 2009 Sep; 189(3):248-52. PubMed ID: 19539015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors.
    Neves MA; Dinis TC; Colombo G; Sá e Melo ML
    Eur J Med Chem; 2009 Oct; 44(10):4121-7. PubMed ID: 19500885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon.
    Zharikova OL; Ravindran S; Nanovskaya TN; Hill RA; Hankins GD; Ahmed MS
    Biochem Pharmacol; 2007 Jun; 73(12):2012-9. PubMed ID: 17462606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical mechanism of aromatization.
    Fishman J
    Cancer Res; 1982 Aug; 42(8 Suppl):3277s-3280s. PubMed ID: 7083186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture.
    Grossman MP; Nakajima ST; Fallat ME; Siow Y
    Fertil Steril; 2008 May; 89(5 Suppl):1364-70. PubMed ID: 17517397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus).
    Chen S; Oh SR; Phung S; Hur G; Ye JJ; Kwok SL; Shrode GE; Belury M; Adams LS; Williams D
    Cancer Res; 2006 Dec; 66(24):12026-34. PubMed ID: 17178902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.